Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Agenus Inc (AGEN) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Agenus Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1098972.
Total stock buying since 2015: $2,550,182.
Total stock sales since 2015: $25,138,031.
Total stock option exercises since 2015: $456,089.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 500,000 | $324,000 | 0 | $0 | 0 | $0 |
| 2023 | 25,000 | $19,000 | 0 | $0 | 0 | $0 |
| 2022 | 0 | $0 | 38,679 | $118,357 | 100,000 | $0 |
| 2021 | 0 | $0 | 93,227 | $605,975 | 152,594 | $456,089 |
| 2020 | 0 | $0 | 791,000 | $2,880,409 | 82,132 | $0 |
| 2018 | 0 | $0 | 0 | $0 | 53,050 | $0 |
| 2017 | 100,000 | $334,508 | 27,737 | $95,981 | 0 | $0 |
| 2016 | 332,250 | $1,319,174 | 0 | $0 | 0 | $0 |
| 2015 | 110,000 | $553,500 | 3,670,583 | $21,437,309 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-02 | 500,000 | $324,000 | 0 | $0 | 0 | $0 |
| 2023-11 | 25,000 | $19,000 | 0 | $0 | 0 | $0 |
| 2022-01 | 0 | $0 | 38,679 | $118,357 | 100,000 | $0 |
| 2021-09 | 0 | $0 | 93,227 | $605,975 | 135,741 | $456,089 |
| 2021-06 | 0 | $0 | 0 | $0 | 16,853 | $0 |
| 2020-06 | 0 | $0 | 791,000 | $2,880,409 | 82,132 | $0 |
| 2018-03 | 0 | $0 | 0 | $0 | 53,050 | $0 |
| 2017-12 | 0 | $0 | 27,737 | $95,981 | 0 | $0 |
| 2017-04 | 100,000 | $334,508 | 0 | $0 | 0 | $0 |
| 2016-09 | 30,000 | $188,700 | 0 | $0 | 0 | $0 |
| 2016-05 | 102,250 | $324,875 | 0 | $0 | 0 | $0 |
| 2016-03 | 200,000 | $805,599 | 0 | $0 | 0 | $0 |
| 2015-12 | 0 | $0 | 219,576 | $1,008,469 | 0 | $0 |
| 2015-09 | 110,000 | $553,500 | 0 | $0 | 0 | $0 |
| 2015-04 | 0 | $0 | 1,107,377 | $7,871,671 | 0 | $0 |
| 2015-01 | 0 | $0 | 2,343,630 | $12,557,169 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-02-15 | Armen Garo H (See Remarks) | Buy | 500,000 | .65 | 324,000 |
| 2023-11-15 | Wiinberg Ulf | Buy | 25,000 | .76 | 19,000 |
| 2022-01-06 | O'day Steven J (Chief Medical Officer) | Sale | 38,679 | 3.06 | 118,357 |
| 2022-01-04 | O'day Steven J (Chief Medical Officer) | Option Ex | 100,000 | .00 | 0 |
| 2021-09-13 | Armen Garo H (Chairman and CEO) | Sale | 82,107 | 6.50 | 533,695 |
| 2021-09-13 | Armen Garo H (Chairman and CEO) | Option Ex | 119,178 | 3.36 | 400,438 |
| 2021-09-10 | Klaskin Christine M (PFO & PAO) | Sale | 11,120 | 6.50 | 72,280 |
| 2021-09-10 | Klaskin Christine M (PFO & PAO) | Option Ex | 16,563 | 3.36 | 55,651 |
| 2021-06-16 | Wiinberg Ulf (Director) | Option Ex | 16,853 | .00 | 0 |
| 2020-06-19 | Jeynes-ellis Allison M (Director) | Option Ex | 20,338 | .00 | 0 |
| 2020-06-19 | Corvese Brian (Director) | Option Ex | 21,118 | .00 | 0 |
| 2020-06-19 | Wright Timothy (Director) | Option Ex | 20,338 | .00 | 0 |
| 2020-06-19 | Wiinberg Ulf (Director) | Option Ex | 20,338 | .00 | 0 |
| 2020-06-17 | Incyte Corp (10% Owner) | Sale | 141,920 | 3.66 | 518,859 |
| 2020-06-16 | Incyte Corp (10% Owner) | Sale | 72,080 | 3.66 | 264,029 |
| 2020-06-15 | Incyte Corp | Sale | 384,025 | 3.57 | 1,372,121 |
| 2020-06-12 | Incyte Corp | Sale | 9,100 | 3.58 | 32,559 |
| 2020-06-11 | Incyte Corp | Sale | 183,875 | 3.77 | 692,841 |
| 2018-03-31 | Corvese Brian (Director) | Option Ex | 21,220 | .00 | 0 |
| 2018-03-31 | Wright Timothy (Director) | Option Ex | 15,915 | .00 | 0 |
| 2018-03-31 | Wiinberg Ulf (Director) | Option Ex | 15,915 | .00 | 0 |
| 2017-12-12 | Buell Jennifer (Chief Communications Officer) | Sale | 3,511 | 3.46 | 12,151 |
| 2017-12-12 | Duncan Alex (Chief Technology Officer) | Sale | 6,546 | 3.46 | 22,649 |
| 2017-12-12 | Baysal Ozer (Chief Commercial Officer) | Sale | 3,712 | 3.46 | 12,847 |
| 2017-12-12 | Valentine Karen (Chief Legal Officer) | Sale | 8,358 | 3.46 | 28,918 |
| 2017-12-12 | Klaskin Christine M (VP, Finance) | Sale | 5,610 | 3.46 | 19,416 |
| 2017-04-12 | Armen Garo H (Chairman & CEO) | Buy | 29,456 | 3.29 | 97,057 |
| 2017-04-10 | Armen Garo H (Chairman & CEO) | Buy | 70,544 | 3.37 | 237,451 |
| 2016-09-06 | Wiinberg Ulf (Director) | Buy | 30,000 | 6.29 | 188,700 |
| 2016-05-09 | Armen Garo H (Chairman & CEO) | Buy | 50,000 | 3.28 | 163,950 |
| 2016-05-05 | Baysal Ozer (Chief Business Officer) | Buy | 2,250 | 3.10 | 6,975 |
| 2016-05-05 | Armen Garo H (Chairman & CEO) | Buy | 50,000 | 3.08 | 153,950 |
| 2016-03-07 | Armen Garo H (Chairman & CEO) | Buy | 200,000 | 4.03 | 805,599 |
| 2015-12-29 | Armen Garo H (Chairman & CEO) | Sale | 85,224 | 4.57 | 389,644 |
| 2015-12-28 | Armen Garo H (Chairman & CEO) | Sale | 134,352 | 4.61 | 618,825 |
| 2015-09-25 | Ballantyne Charles Evan (Chief Financial Officer) | Buy | 10,000 | 5.05 | 50,500 |
| 2015-09-25 | Armen Garo H (Chairman & CEO) | Buy | 100,000 | 5.03 | 503,000 |
| 2015-04-29 | Malik Shahzad | Sale | 407,377 | 7.02 | 2,858,971 |
| 2015-04-28 | Malik Shahzad | Sale | 700,000 | 7.16 | 5,012,700 |
| 2015-01-09 | Qvt Fund V Lp (10% Owner) | Sale | 2,343,630 | 5.36 | 12,557,169 |
Insider trading activities including stock purchases, stock sales, and option exercises of AGEN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Agenus Inc (symbol AGEN, CIK number 1098972) see the Securities and Exchange Commission (SEC) website.